Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

Nurseries can be noisy places. A clutch of three-year-olds gathered round a book shout excitedly. Across the room, a small committee of toddlers negotiates over stickers and string. Outside, key workers encourage pairs of miniature gymnasts while others sing to drowsy babies. And through the cacophony, children’s use of language develops.

For parents collecting their children, the chatter and buzz of childcare settings is always reassuring. All the more so during the pandemic: another day of play and learning is done, with protective measures in place.

Parents are understandably anxious about how the pandemic has affected their pre-schoolers’ development. More than half of the 570 parents surveyed for a recent Sutton Trust report felt that their two-to-four year-olds’ social and emotional development had been negatively affected during the pandemic. A quarter of these parents felt their child’s language growth in particular had suffered. One in five had similar concerns about their physical development.

Read the full article on The Conversation website, contributed to by Alex Hendry, Department of Experimental Psychology.

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.